Autotelic Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Autotelic Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11320
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Autotelic Inc (Autotelic) is a therapeutic drug monitoring company that develops novel treatments using its therapeutic drug monitoring (TDM) services. The company’s pipeline products include devices to improve safety and efficacy of COX-2 inhibitors, paclitaxel nanomedicine, TGF-beta inhibitors, and to improve compliance and treat uncontrolled hypertension. It also holds expertise in developing therapies to treat malignant tumours such as glioma. Autotelic offers its TDM services to decrease the cycle of clinical development, increase the patent life and expand the therapeutic window. The company works in collaboration with other companies to develop therapies using TDM devices. Autotelic is headquartered in Costa Mesa, California, the US.

Autotelic Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autotelic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Autotelic Inc, Medical Devices Deals, 2012 to YTD 2018 9
Autotelic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Autotelic Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Autotelic Acquires Trabedersen from Isarna Therapeutics 11
Venture Financing 12
Autotelic Raises USD0.2 Million in Venture Financing 12
Licensing Agreements 13
Marina Biotech Enters into Development and Licensing Agreement with Autotelic 13
Marina Biotech Enters into Licensing Agreement with Autotelic 14
Autotelic Enters into Licensing Agreement with Marina Biotech 15
Autotelic Inc – Key Competitors 16
Autotelic Inc – Key Employees 17
Autotelic Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Autotelic Inc, Pharmaceuticals & Healthcare, Key Facts 2
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autotelic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autotelic Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Autotelic Inc, Medical Devices Deals, 2012 to YTD 2018 9
Autotelic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Autotelic Acquires Trabedersen from Isarna Therapeutics 11
Autotelic Raises USD0.2 Million in Venture Financing 12
Marina Biotech Enters into Development and Licensing Agreement with Autotelic 13
Marina Biotech Enters into Licensing Agreement with Autotelic 14
Autotelic Enters into Licensing Agreement with Marina Biotech 15
Autotelic Inc, Key Competitors 16
Autotelic Inc, Key Employees 17

List of Figures
Autotelic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autotelic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autotelic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Autotelic Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Autotelic Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kingfisher Plc:企業の戦略・SWOT・財務情報
    Kingfisher Plc - Strategy, SWOT and Corporate Finance Report Summary Kingfisher Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Superior Energy Services Inc (SPN):企業の財務・戦略的SWOT分析
    Superior Energy Services Inc (SPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Scripps Health:企業の戦略的SWOT分析
    Scripps Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • National Australia Bank Limited:企業の戦略・SWOT・財務情報
    National Australia Bank Limited - Strategy, SWOT and Corporate Finance Report Summary National Australia Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • HemaCare Corp (HEMA):医療機器:M&Aディール及び事業提携情報
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, cord blood, and bone marrow. It spans its expertise in isolations, custom cell collections and testing of p …
  • Mitsubishi Materials Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Materials Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Materials Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Rizal Commercial Banking Corp (RCB):企業の財務・戦略的SWOT分析
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • Guided Therapeutics Inc (GTHP):企業の財務・戦略的SWOT分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …
  • Global Marine Systems Ltd:電力:M&Aディール及び事業提携情報
    Summary Global Marine Systems Limited (Global Marine), a subsidiary of Bridgehouse Marine Limited, is a marine technology and engineering company. It provides submarine cable installation, maintenance and engineering services. Its capabilities include project management, subsea cable installation, s …
  • Becton Dickinson and Co (BDX)-製薬・医療分野:企業M&A・提携分析
    Summary Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management …
  • Stantec Inc (STN):企業の財務・戦略的SWOT分析
    Stantec Inc (STN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • 21st Century Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation o …
  • PPC Limited:企業の戦略・SWOT・財務情報
    PPC Limited - Strategy, SWOT and Corporate Finance Report Summary PPC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • nib Holdings Limited:企業の戦略・SWOT・財務情報
    nib Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary nib Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ahli United Bank BSc:企業の戦略・SWOT・財務分析
    Ahli United Bank BSc - Strategy, SWOT and Corporate Finance Report Summary Ahli United Bank BSc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SpareBank 1 SMN:企業の戦略・SWOT・財務分析
    SpareBank 1 SMN - Strategy, SWOT and Corporate Finance Report Summary SpareBank 1 SMN - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mesa Laboratories Inc (MLAB):医療機器:M&Aディール及び事業提携情報
    Summary Mesa Laboratories Inc (Mesa) is a medical device company that manufactures and markets validation and monitoring instruments. The company’s products include mesa biological indicators, DryCal gas flow calibrators, BGI ambient particulate sampling, DialyGuard dialysate meters, SureTorque cap …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …
  • Novanta Inc (NOVT)-医療機器分野:企業M&A・提携分析
    Summary Novanta Inc (Novanta), formerly GSI Group Inc. is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam d …
  • Nuo Therapeutics Inc (AURX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆